RHEUMATIC DISEASE CLINICS OF NORTH AMERICA
Consulting Editor
MICHAEL H. WEISMAN
February 2017 • Volume 43 • Number 1
Related posts:
Infection and Malignancy in Rheumatic Diseases
Infection and Malignancy in Rheumatic Diseases
Vaccines and Disease-Modifying Antirheumatic Drugs
Immune-Related Adverse Effects of Cancer Immunotherapy— Implications for Rheumatology
Malignancy and Janus Kinase Inhibition
The Risk of Progressive Multifocal Leukoencephalopathy in the Biologic Era